MCS
The Marcus Corporation
MCS's fundamentals are strong: its operating margin rose 3 points to 4.9% and free cash flow grew more than tenfold. At 34x earnings, it's trading below its usual 42x. Analysts expect strong earnings growth, though they disagree widely on how much.
NBIS
Nebius Group N.V.
There isn't enough reported data to score NBIS yet.
MCS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
MCS's revenue, profitability, cash flow and balance sheet are all currently healthy.
NBIS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Healthy |
NBIS's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.
MCS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 31x | $27.22 | — |
| Cheap | 32x | $24.94 | -8.4% |
| Current | 34x | $27.22 | — |
| Fair | 42x | $33.12 | +22% |
| Expensive | 429x | $339 | +1145% |
Historical ranges are pointers, not guarantees.
MCS has the edge over NBIS in the historical PE scenario, which offers more potential upside but is not a forecast.
NBIS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 68x | $22.45 | -83% |
| Fair | 114x | $37.67 | -71% |
| Current | 390x | $129 | — |
| Expensive | 666x | $220 | +71% |
Historical ranges are pointers, not guarantees.
NBIS's PE is 390x, but its earnings don't support one, so it isn't a reliable read right now.
MCS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect MCS's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
NBIS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect NBIS's revenue to grow and its profitability to improve, with its earnings holding steady. However, they disagree widely on these estimates.
MCS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.87 | +10% |
| Q3 2026 | $0.79 | +216% |
| Q2 2026 | $0.71 | +54% |
| Q1 2026 | $0.44 | +$0.84 |
| Q4 2025 | $0.41 | +$0.65 |
| Q3 2025 | $0.25 | +$0.49 |
| Q2 2025 | $0.46 | +$1.13 |
| Q1 2025 | -$0.40 | -238% |
| Q4 2024 | -$0.24 | -167% |
MCS has the edge over NBIS in the latest year-over-year earnings comparison.
NBIS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $0.33 | +$2.61 |
| Q4 2024 | -$2.28 | -456% |
| Q4 2023 | $0.64 | -36% |
| Q4 2022 | $1.00 | +$1.49 |
| Q4 2021 | -$0.49 | -156% |
| Q4 2020 | $0.87 | +89% |
| Q4 2019 | $0.46 | -73% |
| Q4 2018 | $1.71 | +434% |
NBIS has returned to profit: it earned $0.33 per share over the past year, after losing money the year before.
MCS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $237.8M | +13% |
| Q2 2026 | $231.7M | +12% |
| Q1 2026 | $154.4M | +3.8% |
| Q4 2025 | $193.5M | +2.8% |
| Q3 2025 | $210.2M | -9.7% |
| Q2 2025 | $206M | +17% |
| Q1 2025 | $148.8M | +7.4% |
| Q4 2024 | $188.3M | +17% |
MCS has the edge over NBIS in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 13% | +1.9 points |
| Q2 2026 | 12% | +5.4 points |
| Q1 2026 | -12% | +1.3 points |
| Q4 2025 | 0.9% | +2.1 points |
| Q3 2025 | 11% | -3.3 points |
| Q2 2025 | 6.3% | +5 points |
| Q1 2025 | -14% | -1.7 points |
| Q4 2024 | -1.2% | -1.9 points |
MCS's operating margin was 13% last quarter, up 1.9 points from the same quarter a year ago, near the top of its range since 2019.
NBIS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2023 | $9.7B | +53% |
| Q4 2022 | $6.3B | +46% |
| Q4 2021 | $4.3B | +63% |
| Q4 2020 | $2.6B | +24% |
| Q4 2019 | $2.1B | +37% |
| Q4 2018 | $1.5B | +36% |
| Q4 2017 | $1.1B | +24% |
| Q4 2016 | $917M | +27% |
NBIS's revenue is growing: $530M last quarter, down 80% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -115% | -112 points |
| Q4 2023 | 3.6% | -11 points |
| Q4 2022 | 2.5% | -14 points |
| Q4 2021 | -3.7% | -18 points |
| Q4 2020 | 7.4% | -9.5 points |
| Q4 2019 | 14% | -2 points |
| Q4 2018 | 16% | -14 points |
| Q4 2017 | 14% | -19 points |
NBIS's operating margin was −115% last quarter, down 123 points from the same quarter a year ago, near the bottom of its range since 2011.
MCS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $28.4M | +56% |
| Q2 2026 | $44M | +198% |
| Q1 2026 | -$21.9M | +$36.5M |
| Q4 2025 | $26.4M | -2.7% |
| Q3 2025 | $18.2M | +51% |
| Q2 2025 | $14.7M | -8.7% |
| Q1 2025 | -$58.3M | -$27.8M |
| Q4 2024 | $27.1M | +29% |
MCS generated $77M in free cash flow over the past year, more than ten times what it generated the year before.
NBIS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$3.7B | -$3.1B |
| Q4 2024 | -$562.1M | -$316.2M |
| Q4 2023 | -$245.9M | -$138.9M |
| Q4 2022 | -$107M | +$319.7M |
| Q4 2021 | -$426.7M | -539% |
| Q4 2020 | $97.3M | -66% |
| Q4 2019 | $287.9M | +$289.2M |
| Q4 2018 | -$1.3M | -101% |
NBIS has burned cash in six of the last eight quarters: −$4.6B over the past year, against −$43M the year before.
MCS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.5% | +455K shares |
| 1 year | +1.1% | +329K shares |
| 3 years | -23% | -9.5M shares |
| 5 years | +0.3% | +100K shares |
| Available history | +1.1% | +352K shares |
MCS has 32M diluted shares, up 1.1% from a year ago.
NBIS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -12% | -33.3M shares |
| 1 year | -32% | -115M shares |
| 3 years | -26% | -86.9M shares |
NBIS has the edge over MCS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2024 | $10M |
| Q4 2021 | $84.1M |
| Q4 2020 | $122.8M |
| Q4 2019 | $17.2M |
| Q4 2018 | $121.8M |
| Q4 2014 | $101.7M |
| Q4 2013 | $102.9M |
MCS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.8x | Very low |
| Q2 2026 | 1.2x | Healthy |
| Q1 2026 | 1.8x | Healthy |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 1.9x | Healthy |
| Q2 2025 | 1.8x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 1.4x | Healthy |
MCS's net debt is less than a year of its operating earnings (EBITDA), down from 1.9 years a year ago.
NBIS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | 0.7x | Very low |
| Q4 2022 | -0.7x | Net Cash |
NBIS's net debt is less than a year of its operating earnings (EBITDA).
MCS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.6 | Neutral |
| Stochastic | 21.4 | Neutral |
MCS's weekly RSI is 59 (neutral) and its Stochastic is 21 (neutral).
NBIS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 8.3 | Oversold |
NBIS's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).
MCS PE vs Communication Services Sector
| Metric | MCS | Sector median | Relative |
|---|---|---|---|
| PE | 34x | 16x | 109% above |
| PE % | 23 | 26 | 3 pts below |
MCS has the edge over NBIS on valuation relative to its sector.
NBIS PE vs Communication Services Sector
| Metric | NBIS | Sector median | Relative |
|---|---|---|---|
| PE | 390x | 16x | 2,264% above |
| PE % | 62 | 24 | 38 pts above |
NBIS is trading at 390x earnings, a 2264% premium to the Communication Services sector's median of 16x, though its earnings don't support one.
MCS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 0.4% below |
| 20 week MA | $27.1 | 0.6% above |
| 50 week MA | $21.3 | 28% above |
| 100 week MA | $19.2 | 42% above |
| 200 week MA | $17.1 | 59% above |
MCS has stronger trend alignment. MCS is above 4 of 5 weekly averages versus NBIS above 1 of 4.
NBIS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $179.7 | 28% below |
| 20 week MA | $199.9 | 36% below |
| 50 week MA | $163.5 | 21% below |
| 100 week MA | $110.0 | 17% above |
NBIS has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 17% above its 100-week average.
MCS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $31.9 | $12.5 | -61% |
| 2021 | $12.5 | $17.9 | +44% |
| 2022 | $17.9 | $13.9 | -22% |
| 2023 | $13.9 | $14.6 | +4.8% |
| 2024 | $14.6 | $21.4 | +47% |
| 2025 | $21.4 | $15.4 | -28% |
| 2026 YTD | $15.4 | $27.2 | +77% |
MCS has the edge over NBIS on returns for 2026, with the stronger performance.
NBIS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $19.6 | $27.3 | +40% |
| 2025 | $27.3 | $87.6 | +221% |
| 2026 YTD | $87.6 | $128.6 | +47% |
NBIS has finished every year since 2024 higher, and it's up 47% so far in 2026.